Take Renal Stenting Off The Front Lines, Researchers Say
Renal stenting should never be the 1st line of attack for treating patients with hypertension and renal-artery stenosis, according to results from the CORAL clinical trial that were presented during today’s American Heart Assn. Scientific Sessions. The highly anticipated results from the CORAL clinical trial wasn’t great news for renal stents, as researchers reported that…